It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
https://arctichealth.org/en/permalink/ahliterature10861
Source
Lancet. 1998 Apr 18;351(9110):1180-1
Publication Type
Article
Date
Apr-18-1998
More detail
Source
Lancet. 1998 Apr 18;351(9110):1180-1
Date
Apr-18-1998
Language
English
Geographic Location
Sweden
Publication Type
Article
Keywords
Adrenergic beta-Antagonists - adverse effects - therapeutic use
Cardiomyopathy, Dilated - drug therapy - mortality
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Follow-Up Studies
Heart Failure, Congestive - drug therapy - mortality
Heart Transplantation - statistics & numerical data
Humans
Metoprolol - adverse effects - therapeutic use
Research Support, Non-U.S. Gov't
Sweden - epidemiology
Notes
Comment In: Lancet. 1998 Aug 8;352(9126):487-89708781
PubMed ID
9643698
View in PubMed
Less detail
Permalink